Aperio Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $43.4M | Buy |
238,240
+12,000
| +5% | +$2.04M | 0.13% | 155 |
|
|
2020
Q3 | $37.9M | Sell |
226,240
-3,730
| -2% | -$628K | 0.13% | 163 |
|
|
2020
Q2 | $37.4M | Sell |
229,970
-32,279
| -12% | -$5.79M | 0.14% | 151 |
|
|
2020
Q1 | $45.3M | Buy |
262,249
+15,298
| +6% | +$3.04M | 0.2% | 91 |
|
|
2019
Q4 | $49.6M | Buy |
246,951
+19,780
| +9% | +$4.06M | 0.18% | 120 |
|
|
2019
Q3 | $48M | Buy |
227,171
+16,204
| +8% | +$3.39M | 0.19% | 105 |
|
|
2019
Q2 | $41M | Buy |
210,967
+7,573
| +4% | +$1.4M | 0.17% | 124 |
|
|
2019
Q1 | $33.5M | Sell |
203,394
-39,144
| -16% | -$6.92M | 0.14% | 152 |
|
|
2018
Q4 | $45.6M | Buy |
242,538
+20,242
| +9% | +$3.74M | 0.23% | 89 |
|
|
2018
Q3 | $37.8M | Buy |
222,296
+5,930
| +3% | +$998K | 0.17% | 136 |
|
|
2018
Q2 | $35.5M | Buy |
216,366
+6,524
| +3% | +$1.07M | 0.17% | 137 |
|
|
2018
Q1 | $33.9M | Buy |
209,842
+3,502
| +2% | +$557K | 0.17% | 135 |
|
|
2017
Q4 | $30.1M | Buy |
206,340
+6,200
| +3% | +$883K | 0.15% | 149 |
|
|
2017
Q3 | $27.2M | Buy |
200,140
+27,490
| +16% | +$3.47M | 0.15% | 153 |
|
|
2017
Q2 | $21.6M | Buy |
172,650
+18,139
| +12% | +$2.17M | 0.13% | 185 |
|
|
2017
Q1 | $18.4M | Buy |
154,511
+32,668
| +27% | +$3.93M | 0.13% | 193 |
|
|
2016
Q4 | $14.1M | Sell |
121,843
-20,895
| -15% | -$2.33M | 0.11% | 219 |
|
|
2016
Q3 | $14.9M | Buy |
142,738
+9,761
| +7% | +$1.02M | 0.11% | 225 |
|
|
2016
Q2 | $13M | Sell |
132,977
-1,150
| -0.9% | -$109K | 0.1% | 233 |
|
|
2016
Q1 | $12.9M | Buy |
134,127
+23,757
| +22% | +$2.16M | 0.11% | 208 |
|
|
2015
Q4 | $10M | Buy |
110,370
+4,828
| +5% | +$454K | 0.09% | 257 |
|
|
2015
Q3 | $9.79M | Buy |
105,542
+11,542
| +12% | +$1.1M | 0.1% | 241 |
|
|
2015
Q2 | $8.75M | Buy |
94,000
+13,074
| +16% | +$1.22M | 0.09% | 274 |
|
|
2015
Q1 | $7.67M | Buy |
80,926
+5,700
| +8% | +$528K | 0.09% | 294 |
|
|
2014
Q4 | $6.67M | Buy |
75,226
+9,805
| +15% | +$831K | 0.08% | 299 |
|
|
2014
Q3 | $5.23M | Buy |
65,421
+8,393
| +15% | +$633K | 0.07% | 345 |
|
|
2014
Q2 | $4.05M | Sell |
57,028
-13,878
| -20% | -$977K | 0.06% | 386 |
|
|
2014
Q1 | $5.25M | Buy |
+70,906
| New | +$5.35M | 0.07% | 345 |
|
|
2013
Q4 | – | Sell |
-58,091
| Closed | -$4.55M | – | 309 |
|
|
2013
Q3 | $4.29M | Buy |
58,091
+750
| +1% | +$55.3K | 0.08% | 305 |
|
|
2013
Q2 | $4.36M | Buy |
+57,341
| New | +$3.76M | 0.1% | 238 |
|
Other funds holding CME
Aperio Group's CME Position: Q4 2020 in Review
Aperio Group increased its CME Group (CME) stake by 5.3% in Q4 2020, buying an estimated $2.04M and bringing the position to 238,240 shares worth $43.4M. The position accounts for 0.13% of the portfolio, ranked #155.
Aperio Group first reported a position in CME in Q2 2013 and has held it in 30 quarters since. The position peaked at $49.6M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold CME as of Q4 2020.
- Aperio Group held 238,240 shares of CME Group worth $43.4M as of Q4 2020.
- Aperio Group bought 12,000 CME Group shares in Q4 2020, an estimated $2.04M.
- CME Group made up 0.13% of Aperio Group's portfolio in Q4 2020, its #155 holding.
- Aperio Group first reported a position in CME Group in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's CME Group position peaked at $49.6M in Q4 2019.
- 1,031 funds tracked by Wall St. Rank held CME Group as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.